[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Europe Bioactive Substances Market Report 2016

October 2016 | 127 pages | ID: E4DB09FDF32EN
QYResearch

US$ 3,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of Bioactive Substances

Revenue, means the sales value of Bioactive Substances

This report studies sales (consumption) of Bioactive Substances in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering
  • BASF SE (Germany)
  • CP Kelco (US)
  • Cyanotech Corp. (US)
  • Nutrex Hawaii (US)
  • FMC Health and Nutrition (US)
  • NovaMatrix (Norway)
  • GlycoMar Ltd. (UK)
  • Jazz Pharmaceuticals plc (Ireland)
  • Lonza Group Ltd. (Switzerland)
  • Marinova Pty Ltd (Australia)
  • New England Biolabs Inc (US)
  • oceanBASIS GmbH (Germany)
  • PharmaMar S.A (Spain)
  • PML Applications Ltd. (UK)
  • Prolume Ltd (US)
  • BioLume(r), Inc. (US)
  • Royal DSM N.V (Netherlands)
Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Bioactive Substances in these countries, from 2011 to 2021 (forecast), like
  • Germany
  • France
  • UK
  • Russia
  • Italy
  • Spain
  • Benelux
Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into
  • Type I
  • Type II
  • Type III
Split by application, this report focuses on sales, market share and growth rate of Bioactive Substances in each application, can be divided into
  • Foods
  • Nutraceuticals
  • Medicine
  • Cosmetics
  • Research Tools
  • Processing Technologies
  • New Energy Sources
  • Agriculture
  • Industrial
  • Food Safety
Europe Bioactive Substances Market Report 2016

1 BIOACTIVE SUBSTANCES OVERVIEW

1.1 Product Overview and Scope of Bioactive Substances
1.2 Classification of Bioactive Substances
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Bioactive Substances
  1.3.1 Foods
  1.3.2 Nutraceuticals
  1.3.3 Medicine
  1.3.4 Cosmetics
  1.3.5 Research Tools
  1.3.6 Processing Technologies
  1.3.7 New Energy Sources
  1.3.9 Agriculture
  1.3.9 Industrial
  1.3.10 Food Safety
1.4 Bioactive Substances Market by Countries
  1.4.1 Germany Status and Prospect (2011-2021)
  1.4.2 France Status and Prospect (2011-2021)
  1.4.3 UK Status and Prospect (2011-2021)
  1.4.4 Russia Status and Prospect (2011-2021)
  1.4.5 Italy Status and Prospect (2011-2021)
  1.4.6 Spain Status and Prospect (2011-2021)
  1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Bioactive Substances (2011-2021)
  1.5.1 Europe Bioactive Substances Sales and Growth Rate (2011-2021)
  1.5.2 Europe Bioactive Substances Revenue and Growth Rate (2011-2021)

2 EUROPE BIOACTIVE SUBSTANCES BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Europe Bioactive Substances Market Competition by Manufacturers
  2.1.1 Europe Bioactive Substances Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Europe Bioactive Substances Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Bioactive Substances (Volume and Value) by Type
  2.2.1 Europe Bioactive Substances Sales and Market Share by Type (2011-2016)
  2.2.2 Europe Bioactive Substances Revenue and Market Share by Type (2011-2016)
2.3 Europe Bioactive Substances (Volume and Value) by Countries
  2.3.1 Europe Bioactive Substances Sales and Market Share by Countries (2011-2016)
  2.3.2 Europe Bioactive Substances Revenue and Market Share by Countries (2011-2016)
2.4 Europe Bioactive Substances (Volume) by Application

3 GERMANY BIOACTIVE SUBSTANCES (VOLUME, VALUE AND SALES PRICE)

3.1 Germany Bioactive Substances Sales and Value (2011-2016)
  3.1.1 Germany Bioactive Substances Sales and Growth Rate (2011-2016)
  3.1.2 Germany Bioactive Substances Revenue and Growth Rate (2011-2016)
  3.1.3 Germany Bioactive Substances Sales Price Trend (2011-2016)
3.2 Germany Bioactive Substances Sales and Market Share by Manufacturers
3.3 Germany Bioactive Substances Sales and Market Share by Type
3.4 Germany Bioactive Substances Sales and Market Share by Application

4 FRANCE BIOACTIVE SUBSTANCES (VOLUME, VALUE AND SALES PRICE)

4.1 France Bioactive Substances Sales and Value (2011-2016)
  4.1.1 France Bioactive Substances Sales and Growth Rate (2011-2016)
  4.1.2 France Bioactive Substances Revenue and Growth Rate (2011-2016)
  4.1.4 France Bioactive Substances Sales Price Trend (2011-2016)
4.2 France Bioactive Substances Sales and Market Share by Manufacturers
4.3 France Bioactive Substances Sales and Market Share by Type
4.4 France Bioactive Substances Sales and Market Share by Application

5 UK BIOACTIVE SUBSTANCES (VOLUME, VALUE AND SALES PRICE)

5.1 UK Bioactive Substances Sales and Value (2011-2016)
  5.1.1 UK Bioactive Substances Sales and Growth Rate (2011-2016)
  5.1.2 UK Bioactive Substances Revenue and Growth Rate (2011-2016)
  5.1.5 UK Bioactive Substances Sales Price Trend (2011-2016)
5.2 UK Bioactive Substances Sales and Market Share by Manufacturers
5.3 UK Bioactive Substances Sales and Market Share by Type
5.4 UK Bioactive Substances Sales and Market Share by Application

6 RUSSIA BIOACTIVE SUBSTANCES (VOLUME, VALUE AND SALES PRICE)

6.1 Russia Bioactive Substances Sales and Value (2011-2016)
  6.1.1 Russia Bioactive Substances Sales and Growth Rate (2011-2016)
  6.1.2 Russia Bioactive Substances Revenue and Growth Rate (2011-2016)
  6.1.6 Russia Bioactive Substances Sales Price Trend (2011-2016)
6.2 Russia Bioactive Substances Sales and Market Share by Manufacturers
6.3 Russia Bioactive Substances Sales and Market Share by Type
6.4 Russia Bioactive Substances Sales and Market Share by Application

7 ITALY BIOACTIVE SUBSTANCES (VOLUME, VALUE AND SALES PRICE)

7.1 Italy Bioactive Substances Sales and Value (2011-2016)
  7.1.1 Italy Bioactive Substances Sales and Growth Rate (2011-2016)
  7.1.2 Italy Bioactive Substances Revenue and Growth Rate (2011-2016)
  7.1.7 Italy Bioactive Substances Sales Price Trend (2011-2016)
7.2 Italy Bioactive Substances Sales and Market Share by Manufacturers
7.3 Italy Bioactive Substances Sales and Market Share by Type
7.4 Italy Bioactive Substances Sales and Market Share by Application

8 SPAIN BIOACTIVE SUBSTANCES (VOLUME, VALUE AND SALES PRICE)

8.1 Spain Bioactive Substances Sales and Value (2011-2016)
  8.1.1 Spain Bioactive Substances Sales and Growth Rate (2011-2016)
  8.1.2 Spain Bioactive Substances Revenue and Growth Rate (2011-2016)
  8.1.8 Spain Bioactive Substances Sales Price Trend (2011-2016)
8.2 Spain Bioactive Substances Sales and Market Share by Manufacturers
8.3 Spain Bioactive Substances Sales and Market Share by Type
8.4 Spain Bioactive Substances Sales and Market Share by Application

9 BENELUX BIOACTIVE SUBSTANCES (VOLUME, VALUE AND SALES PRICE)

9.1 Benelux Bioactive Substances Sales and Value (2011-2016)
  9.1.1 Benelux Bioactive Substances Sales and Growth Rate (2011-2016)
  9.1.2 Benelux Bioactive Substances Revenue and Growth Rate (2011-2016)
  9.1.9 Benelux Bioactive Substances Sales Price Trend (2011-2016)
9.2 Benelux Bioactive Substances Sales and Market Share by Manufacturers
9.3 Benelux Bioactive Substances Sales and Market Share by Type
9.4 Benelux Bioactive Substances Sales and Market Share by Application

10 EUROPE BIOACTIVE SUBSTANCES MANUFACTURERS ANALYSIS

10.1 BASF SE (Germany)
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Bioactive Substances Product Type, Application and Specification
    10.1.2.1 Type I
    10.1.2.2 Type II
  10.1.3 BASF SE (Germany) Bioactive Substances Sales, Revenue, Price and Gross Margin (2011-2016)
  10.1.4 Main Business/Business Overview
10.2 CP Kelco (US)
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Bioactive Substances Product Type, Application and Specification
    10.2.2.1 Type I
    10.2.2.2 Type II
  10.2.3 CP Kelco (US) Bioactive Substances Sales, Revenue, Price and Gross Margin (2011-2016)
  10.2.4 Main Business/Business Overview
10.3 Cyanotech Corp. (US)
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Bioactive Substances Product Type, Application and Specification
    10.3.2.1 Type I
    10.3.2.2 Type II
  10.3.3 Cyanotech Corp. (US) Bioactive Substances Sales, Revenue, Price and Gross Margin (2011-2016)
  10.3.4 Main Business/Business Overview
10.4 Nutrex Hawaii (US)
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Bioactive Substances Product Type, Application and Specification
    10.4.2.1 Type I
    10.4.2.2 Type II
  10.4.3 Nutrex Hawaii (US) Bioactive Substances Sales, Revenue, Price and Gross Margin (2011-2016)
  10.4.4 Main Business/Business Overview
10.5 FMC Health and Nutrition (US)
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Bioactive Substances Product Type, Application and Specification
    10.5.2.1 Type I
    10.5.2.2 Type II
  10.5.3 FMC Health and Nutrition (US) Bioactive Substances Sales, Revenue, Price and Gross Margin (2011-2016)
  10.5.4 Main Business/Business Overview
10.6 NovaMatrix (Norway)
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Bioactive Substances Product Type, Application and Specification
    10.6.2.1 Type I
    10.6.2.2 Type II
  10.6.3 NovaMatrix (Norway) Bioactive Substances Sales, Revenue, Price and Gross Margin (2011-2016)
  10.6.4 Main Business/Business Overview
10.7 GlycoMar Ltd. (UK)
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Bioactive Substances Product Type, Application and Specification
    10.7.2.1 Type I
    10.7.2.2 Type II
  10.7.3 GlycoMar Ltd. (UK) Bioactive Substances Sales, Revenue, Price and Gross Margin (2011-2016)
  10.7.4 Main Business/Business Overview
10.8 Jazz Pharmaceuticals plc (Ireland)
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Bioactive Substances Product Type, Application and Specification
    10.8.2.1 Type I
    10.8.2.2 Type II
  10.8.3 Jazz Pharmaceuticals plc (Ireland) Bioactive Substances Sales, Revenue, Price and Gross Margin (2011-2016)
  10.8.4 Main Business/Business Overview
10.9 Lonza Group Ltd. (Switzerland)
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Bioactive Substances Product Type, Application and Specification
    10.9.2.1 Type I
    10.9.2.2 Type II
  10.9.3 Lonza Group Ltd. (Switzerland) Bioactive Substances Sales, Revenue, Price and Gross Margin (2011-2016)
  10.9.4 Main Business/Business Overview
10.10 Marinova Pty Ltd (Australia)
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Bioactive Substances Product Type, Application and Specification
    10.10.2.1 Type I
    10.10.2.2 Type II
  10.10.3 Marinova Pty Ltd (Australia) Bioactive Substances Sales, Revenue, Price and Gross Margin (2011-2016)
  10.10.4 Main Business/Business Overview
10.11 New England Biolabs Inc (US)
10.12 oceanBASIS GmbH (Germany)
10.13 PharmaMar S.A (Spain)
10.14 PML Applications Ltd. (UK)
10.15 Prolume Ltd (US)
10.16 BioLume(r), Inc. (US)
10.17 Royal DSM N.V (Netherlands)

11 BIOACTIVE SUBSTANCES MANUFACTURING COST ANALYSIS

11.1 Bioactive Substances Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Bioactive Substances

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Bioactive Substances Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Bioactive Substances Major Manufacturers in 2015
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 EUROPE BIOACTIVE SUBSTANCES MARKET FORECAST (2016-2021)

14.1 Germany Bioactive Substances Sales Forecast (2016-2021)
14.2 France Bioactive Substances Sales Forecast (2016-2021)
14.3 UK Bioactive Substances Sales Forecast (2016-2021)
14.4 Russia Bioactive Substances Sales Forecast (2016-2021)
14.5 Italy Bioactive Substances Sales Forecast (2016-2021)
14.6 Spain Bioactive Substances Sales Forecast (2016-2021)
14.7 Benelux Bioactive Substances Sales Forecast (2016-2021)
14.8 Europe Bioactive Substances Sales Forecast by Type (2016-2021)
14.9 Europe Bioactive Substances Sales Forecast by Application (2016-2021)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

LIST OF TABLES AND FIGURES

Figure Picture of Bioactive Substances
Table Classification of Bioactive Substances
Figure Europe Sales Market Share of Bioactive Substances by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Application of Bioactive Substances
Figure Europe Sales Market Share of Bioactive Substances by Application in 2015
Figure Foods Examples
Figure Nutraceuticals Examples
Figure Medicine Examples
Figure Cosmetics Examples
Figure Research Tools Examples
Figure Processing Technologies Examples
Figure New Energy Sources Examples
Figure Agriculture Examples
Figure Industrial Examples
Figure Food Safety Examples
Figure Germany Bioactive Substances Revenue and Growth Rate (2011-2021)
Figure France Bioactive Substances Revenue and Growth Rate (2011-2021)
Figure UK Bioactive Substances Revenue and Growth Rate (2011-2021)
Figure Russia Bioactive Substances Revenue and Growth Rate (2011-2021)
Figure Italy Bioactive Substances Revenue and Growth Rate (2011-2021)
Figure Spain Bioactive Substances Revenue and Growth Rate (2011-2021)
Figure Benelux Bioactive Substances Revenue and Growth Rate (2011-2021)
Figure Europe Bioactive Substances Sales and Growth Rate (2011-2021)
Figure Europe Bioactive Substances Revenue and Growth Rate (2011-2021)
Table Europe Bioactive Substances Sales of Key Manufacturers (2015 and 2016)
Table Europe Bioactive Substances Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Bioactive Substances Sales Share by Manufacturers
Figure 2016 Bioactive Substances Sales Share by Manufacturers
Table Europe Bioactive Substances Revenue by Manufacturers (2015 and 2016)
Table Europe Bioactive Substances Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Bioactive Substances Revenue Share by Manufacturers
Table 2016 Europe Bioactive Substances Revenue Share by Manufacturers
Table Europe Bioactive Substances Sales and Market Share by Type (2011-2016)
Table Europe Bioactive Substances Sales Share by Type (2011-2016)
Figure Sales Market Share of Bioactive Substances by Type (2011-2016)
Figure Europe Bioactive Substances Sales Growth Rate by Type (2011-2016)
Table Europe Bioactive Substances Revenue and Market Share by Type (2011-2016)
Table Europe Bioactive Substances Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Bioactive Substances by Type (2011-2016)
Figure Europe Bioactive Substances Revenue Growth Rate by Type (2011-2016)
Table Europe Bioactive Substances Sales and Market Share by Countries (2011-2016)
Table Europe Bioactive Substances Sales Share by Countries (2011-2016)
Figure Sales Market Share of Bioactive Substances by Countries (2011-2016)
Table Europe Bioactive Substances Revenue and Market Share by Countries (2011-2016)
Table Europe Bioactive Substances Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Bioactive Substances by Countries (2011-2016)
Table Europe Bioactive Substances Sales and Market Share by Application (2011-2016)
Table Europe Bioactive Substances Sales Share by Application (2011-2016)
Figure Sales Market Share of Bioactive Substances by Application (2011-2016)
Figure Germany Bioactive Substances Sales and Growth Rate (2011-2016)
Figure Germany Bioactive Substances Revenue and Growth Rate (2011-2016)
Figure Germany Bioactive Substances Sales Price Trend (2011-2016)
Table Germany Bioactive Substances Sales by Manufacturers (2015 and 2016)
Table Germany Bioactive Substances Market Share by Manufacturers (2015 and 2016)
Table Germany Bioactive Substances Sales by Type (2015 and 2016)
Table Germany Bioactive Substances Market Share by Type (2015 and 2016)
Table Germany Bioactive Substances Sales by Application (2015 and 2016)
Table Germany Bioactive Substances Market Share by Application (2015 and 2016)
Figure France Bioactive Substances Sales and Growth Rate (2011-2016)
Figure France Bioactive Substances Revenue and Growth Rate (2011-2016)
Figure France Bioactive Substances Sales Price Trend (2011-2016)
Table France Bioactive Substances Sales by Manufacturers (2015 and 2016)
Table France Bioactive Substances Market Share by Manufacturers (2015 and 2016)
Table France Bioactive Substances Sales by Type (2015 and 2016)
Table France Bioactive Substances Market Share by Type (2015 and 2016)
Table France Bioactive Substances Sales by Application (2015 and 2016)
Table France Bioactive Substances Market Share by Application (2015 and 2016)
Figure UK Bioactive Substances Sales and Growth Rate (2011-2016)
Figure UK Bioactive Substances Revenue and Growth Rate (2011-2016)
Figure UK Bioactive Substances Sales Price Trend (2011-2016)
Table UK Bioactive Substances Sales by Manufacturers (2015 and 2016)
Table UK Bioactive Substances Market Share by Manufacturers (2015 and 2016)
Table UK Bioactive Substances Sales by Type (2015 and 2016)
Table UK Bioactive Substances Market Share by Type (2015 and 2016)
Table UK Bioactive Substances Sales by Application (2015 and 2016)
Table UK Bioactive Substances Market Share by Application (2015 and 2016)
Figure Russia Bioactive Substances Sales and Growth Rate (2011-2016)
Figure Russia Bioactive Substances Revenue and Growth Rate (2011-2016)
Figure Russia Bioactive Substances Sales Price Trend (2011-2016)
Table Russia Bioactive Substances Sales by Manufacturers (2015 and 2016)
Table Russia Bioactive Substances Market Share by Manufacturers (2015 and 2016)
Table Russia Bioactive Substances Sales by Type (2015 and 2016)
Table Russia Bioactive Substances Market Share by Type (2015 and 2016)
Table Russia Bioactive Substances Sales by Application (2015 and 2016)
Table Russia Bioactive Substances Market Share by Application (2015 and 2016)
Figure Italy Bioactive Substances Sales and Growth Rate (2011-2016)
Figure Italy Bioactive Substances Revenue and Growth Rate (2011-2016)
Figure Italy Bioactive Substances Sales Price Trend (2011-2016)
Table Italy Bioactive Substances Sales by Manufacturers (2015 and 2016)
Table Italy Bioactive Substances Market Share by Manufacturers (2015 and 2016)
Table Italy Bioactive Substances Sales by Type (2015 and 2016)
Table Italy Bioactive Substances Market Share by Type (2015 and 2016)
Table Italy Bioactive Substances Sales by Application (2015 and 2016)
Table Italy Bioactive Substances Market Share by Application (2015 and 2016)
Figure Spain Bioactive Substances Sales and Growth Rate (2011-2016)
Figure Spain Bioactive Substances Revenue and Growth Rate (2011-2016)
Figure Spain Bioactive Substances Sales Price Trend (2011-2016)
Table Spain Bioactive Substances Sales by Manufacturers (2015 and 2016)
Table Spain Bioactive Substances Market Share by Manufacturers (2015 and 2016)
Table Spain Bioactive Substances Sales by Type (2015 and 2016)
Table Spain Bioactive Substances Market Share by Type (2015 and 2016)
Table Spain Bioactive Substances Sales by Application (2015 and 2016)
Table Spain Bioactive Substances Market Share by Application (2015 and 2016)
Figure Benelux Bioactive Substances Sales and Growth Rate (2011-2016)
Figure Benelux Bioactive Substances Revenue and Growth Rate (2011-2016)
Figure Benelux Bioactive Substances Sales Price Trend (2011-2016)
Table Benelux Bioactive Substances Sales by Manufacturers (2015 and 2016)
Table Benelux Bioactive Substances Market Share by Manufacturers (2015 and 2016)
Table Benelux Bioactive Substances Sales by Type (2015 and 2016)
Table Benelux Bioactive Substances Market Share by Type (2015 and 2016)
Table Benelux Bioactive Substances Sales by Application (2015 and 2016)
Table Benelux Bioactive Substances Market Share by Application (2015 and 2016)
Table Bioactive Substances Basic Information List
Table BASF SE (Germany) Bioactive Substances Sales, Revenue, Price and Gross Margin (2011-2016)
Figure BASF SE (Germany) Bioactive Substances Sales Market Share (2011-2016)
Table CP Kelco (US) Basic Information List
Table CP Kelco (US) Bioactive Substances Sales, Revenue, Price and Gross Margin (2011-2016)
Table CP Kelco (US) Bioactive Substances Sales Market Share (2011-2016)
Table Cyanotech Corp. (US) Basic Information List
Table Cyanotech Corp. (US) Bioactive Substances Sales, Revenue, Price and Gross Margin (2011-2016)
Table Cyanotech Corp. (US) Bioactive Substances Sales Market Share (2011-2016)
Table Nutrex Hawaii (US) Basic Information List
Table Nutrex Hawaii (US) Bioactive Substances Sales, Revenue, Price and Gross Margin (2011-2016)
Table Nutrex Hawaii (US) Bioactive Substances Sales Market Share (2011-2016)
Table FMC Health and Nutrition (US) Basic Information List
Table FMC Health and Nutrition (US) Bioactive Substances Sales, Revenue, Price and Gross Margin (2011-2016)
Table FMC Health and Nutrition (US) Bioactive Substances Sales Market Share (2011-2016)
Table NovaMatrix (Norway) Basic Information List
Table NovaMatrix (Norway) Bioactive Substances Sales, Revenue, Price and Gross Margin (2011-2016)
Table NovaMatrix (Norway) Bioactive Substances Sales Market Share (2011-2016)
Table GlycoMar Ltd. (UK) Basic Information List
Table GlycoMar Ltd. (UK) Bioactive Substances Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlycoMar Ltd. (UK) Bioactive Substances Sales Market Share (2011-2016)
Table Jazz Pharmaceuticals plc (Ireland) Basic Information List
Table Jazz Pharmaceuticals plc (Ireland) Bioactive Substances Sales, Revenue, Price and Gross Margin (2011-2016)
Table Jazz Pharmaceuticals plc (Ireland) Bioactive Substances Sales Market Share (2011-2016)
Table Lonza Group Ltd. (Switzerland) Basic Information List
Table Lonza Group Ltd. (Switzerland) Bioactive Substances Sales, Revenue, Price and Gross Margin (2011-2016)
Table Lonza Group Ltd. (Switzerland) Bioactive Substances Sales Market Share (2011-2016)
Table Marinova Pty Ltd (Australia) Basic Information List
Table Marinova Pty Ltd (Australia) Bioactive Substances Sales, Revenue, Price and Gross Margin (2011-2016)
Table Marinova Pty Ltd (Australia) Bioactive Substances Sales Market Share (2011-2016)
Table New England Biolabs Inc (US) Basic Information List
Table New England Biolabs Inc (US) Bioactive Substances Sales, Revenue, Price and Gross Margin (2011-2016)
Table New England Biolabs Inc (US) Bioactive Substances Sales Market Share (2011-2016)
Table oceanBASIS GmbH (Germany) Basic Information List
Table oceanBASIS GmbH (Germany) Bioactive Substances Sales, Revenue, Price and Gross Margin (2011-2016)
Table oceanBASIS GmbH (Germany) Bioactive Substances Sales Market Share (2011-2016)
Table PharmaMar S.A (Spain) Basic Information List
Table PharmaMar S.A (Spain) Bioactive Substances Sales, Revenue, Price and Gross Margin (2011-2016)
Table PharmaMar S.A (Spain) Bioactive Substances Sales Market Share (2011-2016)
Table PML Applications Ltd. (UK) Basic Information List
Table PML Applications Ltd. (UK) Bioactive Substances Sales, Revenue, Price and Gross Margin (2011-2016)
Table PML Applications Ltd. (UK) Bioactive Substances Sales Market Share (2011-2016)
Table Prolume Ltd (US) Basic Information List
Table Prolume Ltd (US) Bioactive Substances Sales, Revenue, Price and Gross Margin (2011-2016)
Table Prolume Ltd (US) Bioactive Substances Sales Market Share (2011-2016)
Table BioLume(r), Inc. (US) Basic Information List
Table BioLume(r), Inc. (US) Bioactive Substances Sales, Revenue, Price and Gross Margin (2011-2016)
Table BioLume(r), Inc. (US) Bioactive Substances Sales Market Share (2011-2016)
Table Royal DSM N.V (Netherlands) Basic Information List
Table Royal DSM N.V (Netherlands) Bioactive Substances Sales, Revenue, Price and Gross Margin (2011-2016)
Table Royal DSM N.V (Netherlands) Bioactive Substances Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Bioactive Substances
Figure Manufacturing Process Analysis of Bioactive Substances
Figure Bioactive Substances Industrial Chain Analysis
Table Raw Materials Sources of Bioactive Substances Major Manufacturers in 2015
Table Major Buyers of Bioactive Substances
Table Distributors/Traders List
Figure Germany Bioactive Substances Sales and Growth Rate Forecast (2016-2021)
Figure Germany Bioactive Substances Revenue and Growth Rate Forecast (2016-2021)
Figure France Bioactive Substances Sales and Growth Rate Forecast (2016-2021)
Figure France Bioactive Substances Revenue and Growth Rate Forecast (2016-2021)
Figure UK Bioactive Substances Sales and Growth Rate Forecast (2016-2021)
Figure UK Bioactive Substances Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Bioactive Substances Sales and Growth Rate Forecast (2016-2021)
Figure Russia Bioactive Substances Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Bioactive Substances Sales and Growth Rate Forecast (2016-2021)
Figure Italy Bioactive Substances Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Bioactive Substances Sales and Growth Rate Forecast (2016-2021)
Figure Spain Bioactive Substances Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Bioactive Substances Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Bioactive Substances Revenue and Growth Rate Forecast (2016-2021)
Table Europe Bioactive Substances Sales Forecast by Type (2016-2021)
Table Europe Bioactive Substances Sales Forecast by Application (2016-2021)


More Publications